Posted inMedical Technology
Guardant Health gets FDA nod to expand use of blood test for colon cancer
Guardant Health snagged the FDA green light to use its Guardant360 CDx colon cancer diagnostic along with Pfizer’s colon and…
Posted inMedical Technology
Feds charge former Zynex execs in massive medtech billing fraud case
A federal grand jury in Rhode Island has charged two former top executives of Colorado-based medical device company Zynex Inc.…
Posted inMedical Technology
J. Craig Venter launches genomics startup designed to boost diagnostic insights
Genomics and life sciences pioneer J. Craig Venter, Ph.D., is back with a new J. Craig Venter Institute (JCVI) spinoff…
Posted inMedical Technology
Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings
Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses…
Posted inMedical Technology
NeuroQure debuts test to ID autism risk at birth critical for earlier intervention
NeuroQure, a startup diagnostics medtech that formed in 2023, has launched a first-of-its-kind test that can identify autism risk at…
Posted inMedical Technology
Bristol Myers Squibb taps Microsoft’s AI detection network for speedy lung cancer diagnosis
Microsoft and Bristol Myers Squibb have signed a new pact aimed at identifying lung cancer cases more quickly. The U.S.…
Posted inMedical Technology
Guardant Health pens Merck & Co. cancer collab for next-gen tests, companion diagnostics
Guardant Health is signing up to a multiyear deal with Merck & Co. for the U.S. Big Pharma to tap…
Posted inMedical Technology
Abbott, AtaCor join forces on extravascular defibrillator implant
Abbott is teaming up with AtaCor Medical to develop a next-generation implantable cardioverter defibrillator (ICD) designed to treat dangerous cardiac…
Posted inMedical Technology
Boston Scientific to snap up thrombectomy specialist Penumbra in deal valued at $14.5B
Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to…
Posted inMedical Technology
JPM26: Illumina working with China on ‘a path through’ its export troubles, sees academic research environment ‘muted’ for ’26
Looking to usher in a more “predictable” year in 2026, Illumina is working with officials in China as it remains…